Methods for the identification of antiviral compounds
CA 2445911 C · Owner: Uytdehaag, Alphonsus Gerardus Cornelis Maria · Inventors: Brus, Ronald Hendrik Peter; Schouten, Govert Johan; Uytdehaag, Alphonsus Gerardus Cornelis Maria
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides novel methods for determining whether a compound influences a phase in the life cycle of a virus comprising providing a cell with said compound and with at least a fragment of said virus sufficient for performing said phase and determing whether said phase is influenced in said cell, said cell comprising a nucleic acid encoding an adenovirus early protein or a functional part derivative and/or analogue of , said adenovirus early protein. In another aspect the invention provides the use of a cell, said cell comprising nucleic acid encoding an adenovirus early protein, for screening a library of compounds for the presence of a compound capable of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 6, 2002 and granted May 24, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 6, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 6, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.